FICS - ETF AI Analysis
Top Page
First Trust International Developed Capital Strength ETF (FICS)
FICS, the First Trust International Developed Capital Strength ETF, has a solid overall rating, supported by strong holdings like DBS Group Holdings and Royal Bank of Canada, which bring robust profitability, positive earnings sentiment, and sound strategic initiatives to the portfolio. However, some companies such as Compass and Unilever face bearish technical trends and relatively high valuations, and several holdings show signs of potential overvaluation or overbought conditions, creating a key risk that the fund may be somewhat exposed to short-term price corrections despite its generally strong fundamentals.
FICS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 203.21M
- Region
- Developed Markets
- Expense Ratio
- 0.70%
- Beta
- 0.49
- Issuer
- First Trust
- Inception Date
- Dec 15, 2020
- Dividend Yield
- 1.87%
- Asset Class
- Equity
- Index Tracked
- The International Developed Capital Strength Index
FICS Summary
The First Trust International Developed Capital Strength ETF (FICS) tracks the International Developed Capital Strength Index, focusing on financially strong companies in developed markets outside the U.S. It holds firms from countries like Switzerland, Canada, and France across many sectors, including financials, consumer goods, and health care. Well-known names include L’Oreal and Roche. Someone might invest in FICS to add global diversification and gain exposure to solid, established companies overseas. A key risk is that international stock prices can go up and down with global markets and currency changes, so the value of this ETF can be volatile.
How much will it cost me?
This ETF has an expense ratio of 0.70%, which means you’ll pay about $7 per year for every $1,000 you invest. That’s higher than the average ETF cost because it’s more actively managed, focusing on financially strong companies in developed markets outside the U.S.
What would affect this ETF?
FICS could benefit if developed markets outside the U.S. grow steadily, consumer and health care companies like Nestlé and Roche maintain strong demand, and financial and energy holdings gain from stable interest rates and commodity prices. On the other hand, slower global growth, rising rates that pressure international stocks, regulatory changes affecting foreign financial and energy firms, or currency swings between the U.S. and other developed markets could hurt future returns.
FICS Top 10 Holdings
FICS is leaning heavily on financial powerhouses, with Singapore’s DBS Group and Canada’s Great-West Lifeco and TD Bank doing much of the heavy lifting as their shares keep rising and provide a steady backbone for the fund. Royal Bank of Canada adds to that stability, even if its momentum has cooled a bit. On the consumer side, Swiss hearing-aid maker Sonova is quietly climbing, while Unilever’s mixed, stop‑and‑go performance and Aristocrat Leisure’s recent slide act as a drag. Overall, it’s a developed‑markets ex‑U.S. story dominated by banks and defensives.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Schindler Holding AG | 2.24% | $4.55M | CHF 31.66B | 6.09% | 68Neutral | |
| L'Oreal | 2.12% | $4.31M | EUR 232.44B | 18.95% | 71Outperform | |
| Astellas Pharma | ― | ― | ― | ― | 69Neutral | |
| Telstra Corporation Limited | 2.10% | $4.28M | AUD 54.81B | 2.06% | 64Neutral | |
| SGS SA | 2.10% | $4.28M | CHF 20.60B | 13.95% | 66Neutral | |
| Shionogi & Co | 2.04% | $4.15M | JPY 2.65T | 21.28% | 75Outperform | |
| Roche Holding AG | ― | ― | ― | ― | 73Outperform | |
| Coca Cola HBC | 2.12% | $4.32M | GBP 17.14B | 35.72% | 78Outperform | |
| Aena SA | 2.08% | $4.23M | EUR 40.62B | 13.73% | 80Outperform | |
| Canadian Bank of Commerce | 2.06% | $4.21M | CAD 147.95B | 41.39% | 74Outperform |
FICS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FICS, the sentiment is Positive. The current price of 41.67 is above the 20-day moving average (MA) of 40.80, above the 50-day MA of 41.12, and above the 200-day MA of 40.67, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 62.06 is Neutral, neither overbought nor oversold. The STOCH value of 66.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FICS.
FICS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $41.67 | $45.00(7.99% Upside) | $203.21M | 0.70% | 70Outperform | |
| $40.16 | $43.46(8.22% Upside) | $753.10M | 0.59% | 62Neutral | |
| $99.42 | $116.59(17.27% Upside) | $665.28M | 0.39% | 65Neutral | |
| $34.70 | $39.91(15.01% Upside) | $582.32M | 0.65% | 64Neutral | |
| $40.94 | $50.07(22.29% Upside) | $452.98M | 0.39% | 64Neutral | |
| $78.61 | $91.39(16.26% Upside) | $376.48M | 0.23% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FICS | First Trust International Developed Capital Strength ETF | 41.67 | 4.27 | 11.42% | |
| FYLD | Cambria Foreign Shareholder Yield ETF | 40.16 | 10.06 | 33.40% | |
| TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt | 99.42 | 13.36 | 15.52% | |
| TXUE | Thornburg International Equity ETF | 34.70 | 4.74 | 15.83% | |
| MFDX | PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 40.94 | 4.91 | 13.64% | |
| AVSD | Avantis Responsible International Equity ETF | 78.61 | 8.63 | 12.33% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.